Ascension Health is set to exit medical device maker Apama Medical, which has agreed to an acquisition by Boston Scientific for up to $300m.

Mark Barrett, who has held business development roles at Johnson & Johnson and Sanofi Genzyme, has taken an entrepreneur-in-residence position at Frazier Healthcare Partners.

Tencent led the medical imaging startup's series A+ round, which increased its overall funding to almost $29m.

The biotech spinout will use the cash to fund clinical development and proof-of-concept for its lead candidate targeting influenza by 2018 and 2019.

Insulin developer Thermalin has raised an undisclosed sum from investors including Sanofi and JSR, and plans to close the round at $17.5m.

Magenta, the developer of a heart failure treatment device, has added an Abiomed-backed series B round to the $4m series A it raised five years ago.

Health insurer Premera Blue Cross has backed a $6.1m series A round for Cardinal Analytx, developer of technology that calculates the potential risk of new policy buyers.

Evotec has invested $17.7m in Exscientia, becoming the first strategic shareholder in the drug discovery spinout, which is based on research at University of Dundee.